Ali Tafreshi COSA-IPOS Joint Scientific Meeting 2012

Abstracts this author is presenting:

• Efficacy of sorafenib in advanced renal cell carcinoma (RCC) independent of prior treatment, histology or prognostic group — COSA Best of the Best Orals: Clinical Sciences
• Peri-operative chemotherapy improves relapse-free survival for urothelial carcinoma of the bladder treated by radical cystectomy, but remains under-utilised in an Australian tertiary referral institution — COSA Posters: Clinical Research